These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Mechanisms of drug resistance in epilepsy]. Lasoń W Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of drug resistance. Löscher W Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487 [TBL] [Abstract][Full Text] [Related]
9. The potential of pharmacogenetics in the treatment of epilepsy. Depondt C Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088 [TBL] [Abstract][Full Text] [Related]
10. Refractory epilepsy: clinical overview. French JA Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406 [TBL] [Abstract][Full Text] [Related]
11. The blood-brain barrier and epilepsy. Oby E; Janigro D Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs. Anderson GD Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of antiepileptic drugs. White HS; Smith MD; Wilcox KS Int Rev Neurobiol; 2007; 81():85-110. PubMed ID: 17433919 [TBL] [Abstract][Full Text] [Related]
14. A novel mechanism underlying drug resistance in chronic epilepsy. Remy S; Gabriel S; Urban BW; Dietrich D; Lehmann TN; Elger CE; Heinemann U; Beck H Ann Neurol; 2003 Apr; 53(4):469-79. PubMed ID: 12666114 [TBL] [Abstract][Full Text] [Related]
15. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Rogawski MA Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969 [TBL] [Abstract][Full Text] [Related]
16. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Jonker DM; Voskuyl RA; Danhof M Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245 [TBL] [Abstract][Full Text] [Related]
17. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Kwan P; Brodie MJ Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503 [TBL] [Abstract][Full Text] [Related]
18. In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance. Oby E; Caccia S; Vezzani A; Moeddel G; Hallene K; Guiso G; Said T; Bingaman W; Marchi N; Baumgartner C; Pirker S; Czech T; Lo Russo G; Janigro D Brain Res; 2006 May; 1086(1):201-13. PubMed ID: 16631625 [TBL] [Abstract][Full Text] [Related]
19. Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance. Kim DU; Kim MK; Cho YW; Kim YS; Kim WJ; Lee MG; Kim SE; Nam TS; Cho KH; Kim YO; Lee MC J Hum Genet; 2011 Sep; 56(9):640-6. PubMed ID: 21776001 [TBL] [Abstract][Full Text] [Related]
20. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]